Hemangiopericytoma clinical trials

The registry lists 6 studies for Hemangiopericytoma across more than 10 countries. 2 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-10-13. Counting its narrower condition Hemangiopericytoma, Malignant too: 32 studies, 2 open.

Get an email when these change. Save the Hemangiopericytoma studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 3
Recruiting: 2
Terminated: 1

Phase

Phase 2: 4
Phase 1: 1

Where

United States: 2
Netherlands: 2
Germany: 1
Italy: 1
Norway: 1
Switzerland: 1

Who runs them

Rabin Medical Center (1) · Novartis Pharmaceuticals (1) · Abramson Cancer Center at Penn Medicine (1) · Sarcoma Alliance for Research through Collaboration (1) · European Organisation for Research and Treatment of Cancer - EORTC (1) · Maastricht Radiation Oncology (1)

What is being tested here

Drugs under test in Hemangiopericytoma studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Dasatinib	0	0	1
Imatinib	0	0	1
Pembrolizumab	0	0	1

Who these studies take

Of the 2 Hemangiopericytoma studies recruiting now, 2 (100%) set no upper age limit and 0 (0%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 2
Age	Women	Men
10	0 (0%)	0 (0%)
18	2 (100%)	2 (100%)
30	2 (100%)	2 (100%)
40	2 (100%)	2 (100%)
50	2 (100%)	2 (100%)
65	2 (100%)	2 (100%)
75	2 (100%)	2 (100%)
85	2 (100%)	2 (100%)

Across all 6 studies, recruiting or not: 17% stop at 75 or younger and 0% at 65; 33% take children; 0% are for women only and 0% for men only; 0% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 6 of 6. search them.